spectrum collection small-molecule compound library Search Results


94
TargetMol cancer drug resistance cancerdr database 28
Cancer Drug Resistance Cancerdr Database 28, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cancer drug resistance cancerdr database 28/product/TargetMol
Average 94 stars, based on 1 article reviews
cancer drug resistance cancerdr database 28 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
AbbVie Inc small molecule compound collection
Small Molecule Compound Collection, supplied by AbbVie Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecule compound collection/product/AbbVie Inc
Average 90 stars, based on 1 article reviews
small molecule compound collection - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MicroSource Discovery Systems small molecules
Small Molecules, supplied by MicroSource Discovery Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecules/product/MicroSource Discovery Systems
Average 90 stars, based on 1 article reviews
small molecules - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MicroSource Discovery Systems spectrum collection small molecule library
Spectrum Collection Small Molecule Library, supplied by MicroSource Discovery Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectrum collection small molecule library/product/MicroSource Discovery Systems
Average 90 stars, based on 1 article reviews
spectrum collection small molecule library - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Selleck Chemicals 273 small molecule kinase inhibitors
a. Directed differentiation of Pax6+ (green)/ Nestin+ (red) neural precursor cells (NPCs; DIV 0, left) into TUJ1+ (red)/ TH+ (green) neurons (DIV 21, right). The differentiation protocol and timeline of analysis are shown in the drawing in the middle.. FG2 and FGF8, fibroblast growth factors 2 and 8; SHH, Sonic Hedgehog; AA, ascorbic acid; Scale bar represents BDNF, brain-derived neurotrophic factor; GDNF, glial cell-derived neurotrophic factor (GDNF); cAMP, cyclic AMP. Scale bars, 50 μm. b. Scatter plot showing the ratio of TH versus TUJ1 fluorescence intensity in duplicate upon treatment with 273 <t>small</t> <t>molecule</t> <t>kinase</t> <t>inhibitors.</t> The dots inside the green square correspond to the 4 hit compounds showing significant increase of TH versus TUJ1 fluorescence ratio as compared to the DMSO controls (blue dots). The red arrow indicates BX795. c. Representative images of patient-derived p.A53T-neurons immunolabelled for TH in 384-well plates. Upper micrograph shows control DMSO-treated cells while lower micrograph represents BX795-treated cells. Scale bar represents 150 μm. d. Tests of the four hit compounds in a dose-response format. Data are presented as mean ± SEM.(one-way ANOVA, *P<0.05, n=3 independent experiments).
273 Small Molecule Kinase Inhibitors, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/273 small molecule kinase inhibitors/product/Selleck Chemicals
Average 90 stars, based on 1 article reviews
273 small molecule kinase inhibitors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Pfizer Inc compound 4
a. Directed differentiation of Pax6+ (green)/ Nestin+ (red) neural precursor cells (NPCs; DIV 0, left) into TUJ1+ (red)/ TH+ (green) neurons (DIV 21, right). The differentiation protocol and timeline of analysis are shown in the drawing in the middle.. FG2 and FGF8, fibroblast growth factors 2 and 8; SHH, Sonic Hedgehog; AA, ascorbic acid; Scale bar represents BDNF, brain-derived neurotrophic factor; GDNF, glial cell-derived neurotrophic factor (GDNF); cAMP, cyclic AMP. Scale bars, 50 μm. b. Scatter plot showing the ratio of TH versus TUJ1 fluorescence intensity in duplicate upon treatment with 273 <t>small</t> <t>molecule</t> <t>kinase</t> <t>inhibitors.</t> The dots inside the green square correspond to the 4 hit compounds showing significant increase of TH versus TUJ1 fluorescence ratio as compared to the DMSO controls (blue dots). The red arrow indicates BX795. c. Representative images of patient-derived p.A53T-neurons immunolabelled for TH in 384-well plates. Upper micrograph shows control DMSO-treated cells while lower micrograph represents BX795-treated cells. Scale bar represents 150 μm. d. Tests of the four hit compounds in a dose-response format. Data are presented as mean ± SEM.(one-way ANOVA, *P<0.05, n=3 independent experiments).
Compound 4, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compound 4/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
compound 4 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Discovery Systems Inc spectrum collection
a. Directed differentiation of Pax6+ (green)/ Nestin+ (red) neural precursor cells (NPCs; DIV 0, left) into TUJ1+ (red)/ TH+ (green) neurons (DIV 21, right). The differentiation protocol and timeline of analysis are shown in the drawing in the middle.. FG2 and FGF8, fibroblast growth factors 2 and 8; SHH, Sonic Hedgehog; AA, ascorbic acid; Scale bar represents BDNF, brain-derived neurotrophic factor; GDNF, glial cell-derived neurotrophic factor (GDNF); cAMP, cyclic AMP. Scale bars, 50 μm. b. Scatter plot showing the ratio of TH versus TUJ1 fluorescence intensity in duplicate upon treatment with 273 <t>small</t> <t>molecule</t> <t>kinase</t> <t>inhibitors.</t> The dots inside the green square correspond to the 4 hit compounds showing significant increase of TH versus TUJ1 fluorescence ratio as compared to the DMSO controls (blue dots). The red arrow indicates BX795. c. Representative images of patient-derived p.A53T-neurons immunolabelled for TH in 384-well plates. Upper micrograph shows control DMSO-treated cells while lower micrograph represents BX795-treated cells. Scale bar represents 150 μm. d. Tests of the four hit compounds in a dose-response format. Data are presented as mean ± SEM.(one-way ANOVA, *P<0.05, n=3 independent experiments).
Spectrum Collection, supplied by Discovery Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectrum collection/product/Discovery Systems Inc
Average 90 stars, based on 1 article reviews
spectrum collection - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Chembridge compounds from chembridge cns small molecule collection
Discovery of potentially active compounds through iterative machine learning. a) A pilot set of 1000 compounds randomly chosen from the <t>CNS</t> library was docked against the 10 most populated clusters from each of the 25 segments. The histogram of each compound’s most favored target illustrates that some segments of tau4RD are better able to accommodate <t>small</t> <t>molecule</t> binding. b) PLSR trained on 990 compounds from the pilot set was able to predict the docking scores of the remaining 10 compounds with reasonable accuracy. Pearson correlation coefficients are shown at the bottom of the panel. c) PLSR was used to select compounds from the diverse set of small molecules in the CNS library. Iteration 1 yielded 1000 compounds based on the results and fingerprints of the pilot set. Iteration 2, based on the docking scores and fingerprints of the 2000 compounds from the pilot set and Iteration 1, yielded primarily compounds that had already been examined and docked in Iteration 1. When these were excluded from the library, the next 1000 compounds (“Iter. 2 – new”) displayed worse docking scores on average. This indicated that the PLSR search had largely converged.
Compounds From Chembridge Cns Small Molecule Collection, supplied by Chembridge, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compounds from chembridge cns small molecule collection/product/Chembridge
Average 90 stars, based on 1 article reviews
compounds from chembridge cns small molecule collection - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ASINEX Inc small-molecular compounds
Discovery of potentially active compounds through iterative machine learning. a) A pilot set of 1000 compounds randomly chosen from the <t>CNS</t> library was docked against the 10 most populated clusters from each of the 25 segments. The histogram of each compound’s most favored target illustrates that some segments of tau4RD are better able to accommodate <t>small</t> <t>molecule</t> binding. b) PLSR trained on 990 compounds from the pilot set was able to predict the docking scores of the remaining 10 compounds with reasonable accuracy. Pearson correlation coefficients are shown at the bottom of the panel. c) PLSR was used to select compounds from the diverse set of small molecules in the CNS library. Iteration 1 yielded 1000 compounds based on the results and fingerprints of the pilot set. Iteration 2, based on the docking scores and fingerprints of the 2000 compounds from the pilot set and Iteration 1, yielded primarily compounds that had already been examined and docked in Iteration 1. When these were excluded from the library, the next 1000 compounds (“Iter. 2 – new”) displayed worse docking scores on average. This indicated that the PLSR search had largely converged.
Small Molecular Compounds, supplied by ASINEX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small-molecular compounds/product/ASINEX Inc
Average 90 stars, based on 1 article reviews
small-molecular compounds - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Evotec Inc molecular libraries small molecule repository (mlsmr) library
Discovery of potentially active compounds through iterative machine learning. a) A pilot set of 1000 compounds randomly chosen from the <t>CNS</t> library was docked against the 10 most populated clusters from each of the 25 segments. The histogram of each compound’s most favored target illustrates that some segments of tau4RD are better able to accommodate <t>small</t> <t>molecule</t> binding. b) PLSR trained on 990 compounds from the pilot set was able to predict the docking scores of the remaining 10 compounds with reasonable accuracy. Pearson correlation coefficients are shown at the bottom of the panel. c) PLSR was used to select compounds from the diverse set of small molecules in the CNS library. Iteration 1 yielded 1000 compounds based on the results and fingerprints of the pilot set. Iteration 2, based on the docking scores and fingerprints of the 2000 compounds from the pilot set and Iteration 1, yielded primarily compounds that had already been examined and docked in Iteration 1. When these were excluded from the library, the next 1000 compounds (“Iter. 2 – new”) displayed worse docking scores on average. This indicated that the PLSR search had largely converged.
Molecular Libraries Small Molecule Repository (Mlsmr) Library, supplied by Evotec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molecular libraries small molecule repository (mlsmr) library/product/Evotec Inc
Average 90 stars, based on 1 article reviews
molecular libraries small molecule repository (mlsmr) library - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MicroSource Discovery Systems spectrum collection microsource discovery systems
Discovery of potentially active compounds through iterative machine learning. a) A pilot set of 1000 compounds randomly chosen from the <t>CNS</t> library was docked against the 10 most populated clusters from each of the 25 segments. The histogram of each compound’s most favored target illustrates that some segments of tau4RD are better able to accommodate <t>small</t> <t>molecule</t> binding. b) PLSR trained on 990 compounds from the pilot set was able to predict the docking scores of the remaining 10 compounds with reasonable accuracy. Pearson correlation coefficients are shown at the bottom of the panel. c) PLSR was used to select compounds from the diverse set of small molecules in the CNS library. Iteration 1 yielded 1000 compounds based on the results and fingerprints of the pilot set. Iteration 2, based on the docking scores and fingerprints of the 2000 compounds from the pilot set and Iteration 1, yielded primarily compounds that had already been examined and docked in Iteration 1. When these were excluded from the library, the next 1000 compounds (“Iter. 2 – new”) displayed worse docking scores on average. This indicated that the PLSR search had largely converged.
Spectrum Collection Microsource Discovery Systems, supplied by MicroSource Discovery Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectrum collection microsource discovery systems/product/MicroSource Discovery Systems
Average 90 stars, based on 1 article reviews
spectrum collection microsource discovery systems - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Chembridge express-pick library
Discovery of potentially active compounds through iterative machine learning. a) A pilot set of 1000 compounds randomly chosen from the <t>CNS</t> library was docked against the 10 most populated clusters from each of the 25 segments. The histogram of each compound’s most favored target illustrates that some segments of tau4RD are better able to accommodate <t>small</t> <t>molecule</t> binding. b) PLSR trained on 990 compounds from the pilot set was able to predict the docking scores of the remaining 10 compounds with reasonable accuracy. Pearson correlation coefficients are shown at the bottom of the panel. c) PLSR was used to select compounds from the diverse set of small molecules in the CNS library. Iteration 1 yielded 1000 compounds based on the results and fingerprints of the pilot set. Iteration 2, based on the docking scores and fingerprints of the 2000 compounds from the pilot set and Iteration 1, yielded primarily compounds that had already been examined and docked in Iteration 1. When these were excluded from the library, the next 1000 compounds (“Iter. 2 – new”) displayed worse docking scores on average. This indicated that the PLSR search had largely converged.
Express Pick Library, supplied by Chembridge, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/express-pick library/product/Chembridge
Average 90 stars, based on 1 article reviews
express-pick library - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


a. Directed differentiation of Pax6+ (green)/ Nestin+ (red) neural precursor cells (NPCs; DIV 0, left) into TUJ1+ (red)/ TH+ (green) neurons (DIV 21, right). The differentiation protocol and timeline of analysis are shown in the drawing in the middle.. FG2 and FGF8, fibroblast growth factors 2 and 8; SHH, Sonic Hedgehog; AA, ascorbic acid; Scale bar represents BDNF, brain-derived neurotrophic factor; GDNF, glial cell-derived neurotrophic factor (GDNF); cAMP, cyclic AMP. Scale bars, 50 μm. b. Scatter plot showing the ratio of TH versus TUJ1 fluorescence intensity in duplicate upon treatment with 273 small molecule kinase inhibitors. The dots inside the green square correspond to the 4 hit compounds showing significant increase of TH versus TUJ1 fluorescence ratio as compared to the DMSO controls (blue dots). The red arrow indicates BX795. c. Representative images of patient-derived p.A53T-neurons immunolabelled for TH in 384-well plates. Upper micrograph shows control DMSO-treated cells while lower micrograph represents BX795-treated cells. Scale bar represents 150 μm. d. Tests of the four hit compounds in a dose-response format. Data are presented as mean ± SEM.(one-way ANOVA, *P<0.05, n=3 independent experiments).

Journal: bioRxiv

Article Title: High Content Screening and Proteomic Analysis Identify a Kinase Inhibitor that rescues pathological phenotypes in a Patient-Derived Model of Parkinson’s Disease

doi: 10.1101/2020.06.12.148031

Figure Lengend Snippet: a. Directed differentiation of Pax6+ (green)/ Nestin+ (red) neural precursor cells (NPCs; DIV 0, left) into TUJ1+ (red)/ TH+ (green) neurons (DIV 21, right). The differentiation protocol and timeline of analysis are shown in the drawing in the middle.. FG2 and FGF8, fibroblast growth factors 2 and 8; SHH, Sonic Hedgehog; AA, ascorbic acid; Scale bar represents BDNF, brain-derived neurotrophic factor; GDNF, glial cell-derived neurotrophic factor (GDNF); cAMP, cyclic AMP. Scale bars, 50 μm. b. Scatter plot showing the ratio of TH versus TUJ1 fluorescence intensity in duplicate upon treatment with 273 small molecule kinase inhibitors. The dots inside the green square correspond to the 4 hit compounds showing significant increase of TH versus TUJ1 fluorescence ratio as compared to the DMSO controls (blue dots). The red arrow indicates BX795. c. Representative images of patient-derived p.A53T-neurons immunolabelled for TH in 384-well plates. Upper micrograph shows control DMSO-treated cells while lower micrograph represents BX795-treated cells. Scale bar represents 150 μm. d. Tests of the four hit compounds in a dose-response format. Data are presented as mean ± SEM.(one-way ANOVA, *P<0.05, n=3 independent experiments).

Article Snippet: A collection of 273 small molecule kinase inhibitors from Selleck Chemicals was used.

Techniques: Derivative Assay, Fluorescence

Discovery of potentially active compounds through iterative machine learning. a) A pilot set of 1000 compounds randomly chosen from the CNS library was docked against the 10 most populated clusters from each of the 25 segments. The histogram of each compound’s most favored target illustrates that some segments of tau4RD are better able to accommodate small molecule binding. b) PLSR trained on 990 compounds from the pilot set was able to predict the docking scores of the remaining 10 compounds with reasonable accuracy. Pearson correlation coefficients are shown at the bottom of the panel. c) PLSR was used to select compounds from the diverse set of small molecules in the CNS library. Iteration 1 yielded 1000 compounds based on the results and fingerprints of the pilot set. Iteration 2, based on the docking scores and fingerprints of the 2000 compounds from the pilot set and Iteration 1, yielded primarily compounds that had already been examined and docked in Iteration 1. When these were excluded from the library, the next 1000 compounds (“Iter. 2 – new”) displayed worse docking scores on average. This indicated that the PLSR search had largely converged.

Journal: Biochemistry

Article Title: The Rational Discovery of a Tau Aggregation Inhibitor

doi: 10.1021/acs.biochem.8b00581

Figure Lengend Snippet: Discovery of potentially active compounds through iterative machine learning. a) A pilot set of 1000 compounds randomly chosen from the CNS library was docked against the 10 most populated clusters from each of the 25 segments. The histogram of each compound’s most favored target illustrates that some segments of tau4RD are better able to accommodate small molecule binding. b) PLSR trained on 990 compounds from the pilot set was able to predict the docking scores of the remaining 10 compounds with reasonable accuracy. Pearson correlation coefficients are shown at the bottom of the panel. c) PLSR was used to select compounds from the diverse set of small molecules in the CNS library. Iteration 1 yielded 1000 compounds based on the results and fingerprints of the pilot set. Iteration 2, based on the docking scores and fingerprints of the 2000 compounds from the pilot set and Iteration 1, yielded primarily compounds that had already been examined and docked in Iteration 1. When these were excluded from the library, the next 1000 compounds (“Iter. 2 – new”) displayed worse docking scores on average. This indicated that the PLSR search had largely converged.

Article Snippet: Selected compounds were identified from the ChemBridge CNS small molecule collection, and dry samples were obtained through Hit2Lead (ChemBridge, San Diego, CA).

Techniques: Binding Assay